Get 40% Off
🤑 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

EMERGING MARKETS-Philippine stocks fall as vaccine, economic recovery hopes ebb

Published 12/04/2020, 01:15 PM
Updated 12/04/2020, 01:20 PM
© Reuters
USD/JPY
-
USD/SGD
-
USD/IDR
-
USD/MYR
-
USD/PHP
-
NSEI
-
JKSE
-
KLSE
-
KS11
-
PSI
-
KICI
-
AEV
-
SM
-
SMPH
-
OASA
-
NFCX
-

* Graphic: World FX rates http://tmsnrt.rs/2egbfVh
* Graphic: Foreign flows into Asian stocks https://tmsnrt.rs/3lKhL5I
* Taiwanese dollar, S.Korean won climb 1%
* RBI holds rates as expected

By Shashwat Awasthi
Dec 4 (Reuters) - Philippine shares snapped a three-day
winning run on Friday, hit by a forecast of a deeper economic
contraction in the country this year and news that U.S.
drugmaker Pfizer Inc PFE.N had halved its COVID-19 vaccine
production target for 2020.
Trading across other emerging Asian stock markets remained
mixed as sentiment around downbeat vaccine headlines was partly
offset by hopes that a U.S. coronavirus aid plan would be pushed
through Congress. Stocks in Indonesia .JKSE and Malaysia .KLSE fell 0.4%,
while South Korea's KOSPI .KS11 climbed 1.6% to a record as
shares of chipmakers continued to strengthen.
Manila shares .PSI dropped 0.7% and the peso PHP= eased
after officials on Thursday forecast a 8.5%-9.5% contraction in
the economy, compared with a previous forecast of a 5.5%
decline. The Philippine economy, one of Asia's fastest-growing before
the pandemic, is still expected to rebound strongly over the
next two years and recent upbeat manufacturing and jobs data has
supported the recovery view.
Raul Ruiz, head of research at RCBC Securities, said vaccine
headlines were heavily affecting sentiment as investors had
turned their attention to the speed and magnitude of recovery in
2021.
"In this regard, news that the distribution of Pfizer's
vaccine would be constrained by supply chain issues probably has
more bearing on the market," Ruiz said, also attributing the
fall to profit-taking after a 15% rally in stocks since October.
Indian shares .NSEI advanced, largely unaffected after the
Reserve Bank of India, as widely expected, left its repo rate
unchanged at the end of a three-day policy meeting on Friday.
"The evolving growth-inflation mix suggest that the (Indian)
central bank monetary policy committee would prefer to settle
into a long pause, with a bias to anchor rates through strong
dovish guidance," strategists at Singapore bank DBS said.
Among currencies, the Taiwanese dollar TWD=TP and the
South Korean won KRW=KFTC each jumped more than 1%, while
others failed to make significant headway despite the U.S.
dollar's woes. FRX/

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

HIGHLIGHTS:

** Indonesian 3-year benchmark yields are down 3.6 basis
points at 4.796%
** In the Philippines, top index losers are SM Prime
Holdings SMPH.PS , down 2.82%, Aboitiz Equity Ventures
AEV.PS , off 2.19% and SM Investments SM.PS , down 2.01%
** Top losers on the Jakarta stock index include NFC
Indonesia NFCX.JK , down 6.67%, Protech Mitra Perkasa
OASA.JK , off 6.63% and Kedaung Indah Can KICI.JK , down 6.47%


Asia stock indexes and currencies
at 0423 GMT
COUNTRY FX RIC FX FX YTD INDE STOCK STOC
DAILY % X S KS
% DAILY YTD
% %
Japan JPY= -0.04 +4.56 <.N2 -0.38 12.9
25> 0
China

Latest comments

how to invest here someone can teach me here?
how to invest here someone can teach me here?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.